EGFR and lung cancer: HCPT combined with CRI possessed the synergistic inhibition of proliferation and inducing cell apoptosis by inactivating of EGFR related downstream signalling pathways and the conjugate CH-1 significantly suppressed the lung cancer cell growth with no observed toxicity.